Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2000
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative
10/24/2000US6136832 Racemic mixtures and enantiomorphs
10/24/2000US6136831 Pyrazole derivatives and COX inhibitors containing them
10/24/2000US6136826 Aminopiperidine compounds substituted with alkanoyl
10/24/2000US6136825 Sulfonamide compounds having 5-HT receptor activity
10/24/2000US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
10/24/2000US6136754 Intermediates for pyridyl-thiazoles and their use to protect plants against infections by micro-organisms
10/19/2000WO2000061582A1 Substituted fused imidazole derivatives
10/19/2000WO2000061581A1 Amine derivatives
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061549A2 Pharmaceutical compounds
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000DE19908767A1 New stable, modified epothilone derivatives, are cell division regulators useful for treating malignant tumors, angiogenesis or chronic inflammatory disease
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2370406A1 Pharmaceutical compounds
10/19/2000CA2369971A1 Aryl or heteroaryl fused imidazole derivatives, their pharmaceutical compositions and agents, and uses thereof
10/19/2000CA2368049A1 Integrin receptor ligands
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044195A1 Isothiazolcarboxylic acid derivatives
10/18/2000EP1044191A2 Benzylidene pyrazolones, production and use thereof
10/18/2000EP1044188A1 Acylated 4-aminopyridine derivatives as pesticides and fungicides
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP0773965B1 Gas phase production of polydienes
10/18/2000CN1270589A Epothilone derivatives
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/17/2000US6133459 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
10/17/2000US6133443 Optically active 1,4-dihydropyridine derivatives and process for the preparation thereof
10/17/2000US6133296 Substituted pyridyl keto enols
10/17/2000US6133277 Little or no vasoconstrictor activity; gastrointestinal disorders, e.g. dyspepsia, early satiety, bloating and anorexia; 1-(3-((3,4-dihydro-2h-1-benzopyran-2-yl)methyl)-amino)-propyl)-tetrahydro -2(1h)-primidinone
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133275 3-phenylpyrrolidine alpha-1 adrenergic compounds
10/17/2000US6133270 Isothiazolones and pharmaceutical formulations
10/17/2000CA2202031C Condensed indan derivatives and salts thereof
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/12/2000WO2000059905A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
10/12/2000WO2000059902A2 Aryl sulfonyls as factor xa inhibitors
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059498A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059489A2 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
10/12/2000WO2000009106A3 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2484282A1 Pyrimidine derivatives intermediates for producing aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369557A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2368703A1 Substituted aniline compounds
10/12/2000CA2368630A1 Aryl sulfonyls as factor xa inhibitors
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2363942A1 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043319A1 Novel alkylamino derivatives
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1042327A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
10/11/2000EP1042321A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
10/11/2000EP1042320A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
10/11/2000EP1042315A1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042306A1 Thiazole-, isothiazole- and thiadiazole-derivatives having microbicidal and plant immunizing activities
10/11/2000EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants
10/11/2000EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
10/11/2000EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041977A1 USE OF PPAR-$g(g) ACTIVATORS IN DERMATOLOGY
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000CN1269363A Method for proparing heterocyclic compound
10/11/2000CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000CA2016665C Rhodanine derivatives and pharmaceutical compositions
10/05/2000WO2000058315A1 Organometallic complex molecule and organic electroluminescent device using the same
10/05/2000WO2000058306A1 Substituted benzoylpyrazoles as herbicides
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000058288A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000WO2000058285A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
10/05/2000WO2000058254A1 Synthesis of epothilones
10/05/2000WO2000057874A1 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones
10/05/2000WO2000042026B1 Non-peptide glp-1 agonists
10/05/2000WO2000016765A9 Method and composition for treatment of inflammatory bowel disease
10/05/2000CA2368658A1 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones
10/05/2000CA2368459A1 Substituted benzoylpyrazoles as herbicides
10/05/2000CA2368451A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 628